Navigation Links
Biodel Announces Phase 2 Clinical Trial Initiation Of Ultra-Rapid-Acting Insulin Candidate BIOD-123
Date:9/13/2012

DANBURY, Conn., Sept. 13, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) today announced the initiation of a Phase 2 clinical trial of its proprietary recombinant insulin (RHI)-based ultra-rapid-acting mealtime insulin candidate, BIOD-123.  

"We are pleased to achieve another milestone in the development of BIOD-123. We continue to meet our timelines and project that we will be able to communicate top-line Phase 2 safety and efficacy data in the third calendar quarter of 2013," stated Dr. Errol De Souza, president and chief executive officer of Biodel.

Dr. Alan Krasner, Biodel's Chief Medical Officer, stated:  "This Phase 2 study is designed to assess the clinical impact of the ultra-rapid absorption profile of BIOD-123 relative to currently marketed mealtime insulin analogs.  There is room for improvement in the area of mealtime insulin therapy and we are hopeful that this new candidate will help usher in a new insulin class designed to achieve better meal time outcomes for patients with diabetes."

In April 2012, Biodel announced positive top-line results from a Phase 1 clinical trial of BIOD-123, which demonstrated that the formulation had a more rapid absorption than insulin lispro, sold as Humalog®, with comparable injection site tolerability.

The Phase 2 study is a randomized, open label parallel group study enrolling 130 patients with Type 1 diabetes at approximately 30 U.S. investigative centers. The patients are randomized to receive either BIOD-123 or insulin lispro as their mealtime insulin over an 18 week treatment duration. Both arms of the study use insulin glargine, sold as Lantus®, as the basal insulin. The primary endpoint compares changes in HbA1c, while secondary endpoints compare postprandial glucose excursions, glycemic variability, hypoglycemic event rates and weight changes.

A
'/>"/>

SOURCE Biodel Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioDelivery Sciences to Present at the Stifel Nicolaus 2012 Healthcare Conference
2. BioDelivery Sciences Announces Completion of Enrollment in Pivotal Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone
3. Biodel to Present at 2012 Wedbush PacGrow Lifesciences Management Access Conference
4. BioDelivery Sciences to Present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference
5. BioDelivery Sciences and Endo Health Solutions Announce Initiation of Enrollment in the Phase 3 Program for BEMA Buprenorphine for Chronic Pain
6. Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
7. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
8. Biodel Announces $18.5 Million Private Placement
9. Biodel Obtains Exclusive License to Aegis Therapeutics Technologies for Development and Commercialization of Glucagon Pharmaceutical Formulations
10. Biodel to Report Second Quarter Fiscal Year 2012 Financial Results on May 10, 2012
11. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014 Northwest Biotherapeutics ... company developing DCVax® personalized immune therapies for solid tumor ... product to receive formal designation as a "Promising Innovative ... Scheme" (EAMS) launched in the UK in April 2014. ... process for early access approval under the EAMS.  ...
(Date:9/16/2014)... CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), ... therapeutic products for the prevention and treatment of ... and restatement of its outstanding Series C-2, C-3, ... as well as the warrants issued in its ... remove anti-dilution, price reset and certain change of ...
(Date:9/16/2014)... 16, 2014 Imprimis Pharmaceuticals, Inc. (Nasdaq: ... delivering high quality and novel medicines to physicians and ... Officer Mark Baum will be a presenter ... Conference in New York City.  Mr. Baum will discuss ... campaign in ophthalmology. The presentation is scheduled for 10:40 ...
Breaking Medicine Technology:NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 2NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 3NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 4NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 5CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 3Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 2Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 3Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 4
... Pharmaceuticals, Inc. (NYSE Amex: INO ), a ... against cancers and infectious diseases, announced today the publication ... Vaccines detailing potent immune responses in a preclinical ... targeting two antigens. While current prostate cancer therapies target ...
... Feb. 1, 2011 Anthera Pharmaceuticals, Inc. (Nasdaq: ... treat serious diseases associated with abnormal auto-immune responses and ... Thompson to its Board of Directors. Currently, Dr. Thompson ... founder and Managing Director of Strategicon Partners, an investment ...
Cached Medicine Technology:Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 2Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 3Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 4Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 5Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors 2
(Date:9/16/2014)... (PRWEB) September 17, 2014 Recently, BamboofloorChina.com, ... added a new assortment of strand woven bamboo ... it has launched a big promotion for the new ... off. , Autumn is a great shopping season. ... items for old and new customers. All practical items ...
(Date:9/16/2014)... A nice seat cover is necessary for those who want ... offered by Lseat.com have every item clients need to completely ... protected from everyday wear and tear. , Today, the ... seat covers and launched an autumn special offer. All ... fabric that is both washable and breathable. That brings a ...
(Date:9/16/2014)... Marybeth Cale, owner of Cale Communications , ... in the small village of Rhinebeck, New York, has announced ... a mompreneur, has expanded the business to incorporate a new ... maximize potential. Those services will include group trainings and workshops ... coaching for clients all over the country. , Workshops ...
(Date:9/16/2014)... Retinol is favored by a majority of dermatologists ... has so many benefits - it is one of those ... Sublime Beauty . "Healthy skin is our goal, and ... Beauty® Retinol Serum with Vitamin C is a non-irritating, silky ... The Retinol Serum with Vitamin C is now ...
(Date:9/16/2014)... 2014 Operation Smile was founded “on the ... a facial deformity.” To spread their message and mission, the ... at the Beverly Wilshire Hotel in Beverly Hills, California. The ... whose lives have been forever transformed by the efforts of ... with Operation Smile,” said Lynda Erkiletian, Executive Director of The ...
Breaking Medicine News(10 mins):Health News:BamboofloorChina.com Announces Its Promotion For Strand Woven Bamboo Floors 2Health News:Lseat.com: 2006-2014 Chevrolet Tahoe Chevrolet Tahoe Leather Seat Covers At Discounted Rates 2Health News:Mompreneur Marybeth Cale of Cale Communications Announces Launch Of Life Coaching And Workshop Business 2Health News:Retinol, the Gold Standard in Skin Care, Available in a Serum with Vitamin C from Sublime Beauty®; Now 30% Off 2Health News:James & Paula Coburn Foundation to Host the 2014 Smile Gala, Presented by Operation Smile 2
... 10-30 minutes a day showed significant improvement in social ... Just 10 minutes to 30 minutes of exercise a ... overweight or obese women, American researchers suggest. , ... who took part in the Dose Response to Exercise ...
... can modestly increase the amount of physical activity among ... the Trial of Activity for Adolescent Girls (TAAG), a ... Heart, Lung, and Blood Institute (NHLBI) of the National ... the article, "Promoting Physical Activity in Middle School Girls," ...
... picture of events that underlie the functions of a ... by Cell Press in the journal Molecular Cell, shows ... clock keeps time and may enhance our understanding of ... , A variety of organisms have evolved endogenous timing ...
... 13 Cuyahoga Community College will,celebrate the grand opening ... from 9 a.m. -- noon at the Western Campus, ... -- 9:45 a.m. in the HTC,and building tours will ... 25,000-square-feet, the new Health Technologies Center,includes four classrooms, six ...
... outreach efforts, experts say , , THURSDAY, March 13 (HealthDay ... warning signs of eye diseases that could blind them ... survey shows. , The telephone survey, released Thursday by ... International Foundation, included interviews conducted with 3,000 adults between ...
... -,Best of Show, award winners and ,New and Notables, announced at the ... Aesthetics ... Conference and Expo-, LOS ANGELES, March 13 An ... Los Angeles Spa & Resort,Expo and Conference and Medical Aesthetics Conference and ...
Cached Medicine News:Health News:Minimal Exercise Benefits Overweight Postmenopausal Women 2Health News:After-school programs can increase physical activity of adolescent girls 2Health News:New research provides dynamic visualization of simplest circadian clock 2Health News:Tri-C to Celebrate Health Technologies Center Grand Opening April 4 2Health News:Survey Finds Many Americans Clueless About Eye Disease 2Health News:'Best of Show' Awards Go to Spa and Medical Aesthetics Industry Stars 2Health News:'Best of Show' Awards Go to Spa and Medical Aesthetics Industry Stars 3Health News:'Best of Show' Awards Go to Spa and Medical Aesthetics Industry Stars 4Health News:'Best of Show' Awards Go to Spa and Medical Aesthetics Industry Stars 5
Castroviejo "HM" Micro Needle Holder with Tungsten-Carbide Inserts, with catch. Serrated....
Curved with catch....
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Medium weight bone cutter....
Medicine Products: